Pulmonx (LUNG) Fundamental Analysis: Revenue, Earnings & Valuation

1.03 / 10

Underperform

Fundamental analysis rates Pulmonx as Underperform with a 1.0/10 score. Profit‑MV and Net profit/Total profit are relatively strong, but Revenue‑MV, Cash‑MV, ROA and profit margins are weak, indicating limited growth potential and financial strain.

Analysis Checks(2/10)

Revenue-MV

Value0.21

Score0/3

Weight46.73%

1M Return-4.18%

ROA (%)

Value-36.97

Score1/3

Weight9.74%

1M Return-0.82%

Net cash flow from operating activities / Operating revenue (%)

Value-35.78

Score1/3

Weight15.36%

1M Return-1.35%

Profit-MV

Value0.66

Score2/3

Weight-44.13%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-36.97

Score1/3

Weight9.74%

1M Return-0.82%

EBIT / Total operating revenue (%)

Value-58.43

Score1/3

Weight8.68%

1M Return-0.83%

Asset-MV

Value-0.55

Score1/3

Weight-4.71%

1M Return0.38%

Net profit / Total operating revenue (%)

Value-59.67

Score1/3

Weight9.92%

1M Return-0.84%

Cash-MV

Value0.02

Score1/3

Weight41.84%

1M Return-4.16%

Net profit / Total profit (%)

Value101.17

Score2/3

Weight6.84%

1M Return-0.54%

Is LUNG fundamentally strong?

LUNG scores 1.03/10 on fundamentals and holds a Premium valuation at present. Backed by its -77.19% ROE, -59.67% net margin, -1.00 P/E ratio, 1.00 P/B ratio, and 7.64% earnings growth, these metrics solidify its Underperform investment rating.